Machida, Japan

Masayuki Teranishi


Average Co-Inventor Count = 5.2

ph-index = 5

Forward Citations = 102(Granted Patents)


Location History:

  • Machida, JA (1976)
  • Machida, JP (1979 - 1987)
  • Tokyo, JP (1987)

Company Filing History:


Years Active: 1976-1987

Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovations of Masayuki Teranishi

Introduction

Masayuki Teranishi is a prominent inventor based in Machida, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 10 patents. His work primarily focuses on developing compounds that exhibit therapeutic effects, particularly in the treatment of hypertension and related conditions.

Latest Patents

Among his latest patents, Teranishi has developed phosphorus-containing peptide derivatives. These compounds are synthesized through innovative methods and demonstrate angiotensin-converting enzyme-inhibiting action, making them valuable as anti-hypertensive agents. Another notable patent involves a quinoline-N-oxide derivative, which has a complex structure that allows it to strongly inhibit lipoxygenase. This inhibition is crucial as it helps prevent and heal diseases caused by lipoxygenase metabolites.

Career Highlights

Throughout his career, Masayuki Teranishi has worked with notable companies such as Kyowa Hakko Kogyo Co., Ltd. and Kyowa Hakko Kogyo Kabushiki Kaisha. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include Kazuhiro Kubo and Katsuichi Shuto. Their collaborative efforts have further advanced the research and development of innovative pharmaceutical solutions.

Conclusion

Masayuki Teranishi's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to impact the development of effective treatments for various health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…